Ovid Therapeutics Inc (OVID) - Total Liabilities

Latest as of December 2025: $20.27 Million USD

Based on the latest financial reports, Ovid Therapeutics Inc (OVID) has total liabilities worth $20.27 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Ovid Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.

Ovid Therapeutics Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Ovid Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Ovid Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.

Ovid Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Ovid Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
S.C. CHIMCOMPLEX S.A. RO:CRC	Romania	RON990.32 Million
Websol Energy System Limited NSE:WEBELSOLAR	India	Rs3.17 Billion
BOE Tech Group SHE:200725	China	HK$227.24 Billion
Kernex Microsystems (India) Limited NSE:KERNEX	India	Rs6.72 Billion
D&O Home Collection Co Ltd SHE:002798	China	CN¥3.05 Billion
China Merchants Port Group Co Ltd SHE:201872	China	CN¥72.56 Billion
Banestes S.A - Banco do Estado do Espírito Santo SA:BEES3	Brazil	R$36.68 Billion
General Oceans ASA OL:GENO	Norway	Nkr696.55 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Ovid Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OVID market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	10.91	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ovid Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ovid Therapeutics Inc (2014–2025)

The table below shows the annual total liabilities of Ovid Therapeutics Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	$20.27 Million	-15.32%
2024-12-31	$23.94 Million	-57.42%
2023-12-31	$56.23 Million	+144.55%
2022-12-31	$22.99 Million	+55.38%
2021-12-31	$14.80 Million	-54.18%
2020-12-31	$32.29 Million	+198.46%
2019-12-31	$10.82 Million	+22.34%
2018-12-31	$8.84 Million	+46.89%
2017-12-31	$6.02 Million	+61.28%
2016-12-31	$3.73 Million	+61.68%
2015-12-31	$2.31 Million	+1825.09%
2014-12-31	$119.95K	--

About Ovid Therapeutics Inc

NASDAQ:OVID USA Biotechnology

Market Cap

$439.51 Million

Market Cap Rank

#12859 Global

#3155 in USA

Share Price

$2.54

Change (1 day)

+9.01%

52-Week Range

$0.51 - $2.96

All Time High

$15.00